Bicycle Therapeutics plc (BCYC) Misses Q3 EPS by 6c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q3 EPS of ($1.26), $0.06 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $5.35 million versus the consensus estimate of $12.94 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Genesco (GCO) Tops Q2 EPS by 54c ; Offers Guidance
• ScottsMiracle-Gro to acquire Black Kow brand, deal expected to close in October
• C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance